Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue

被引:19
作者
Saenz-Lopez, P. [1 ]
Gouttefangeas, C. [2 ]
Hennenlotter, J. [3 ]
Concha, A. [4 ]
Maleno, I. [1 ]
Ruiz-Cabello, F. [1 ,5 ]
Cozar, J. M. [6 ]
Tallada, M. [6 ]
Stenzl, A. [3 ]
Rammensee, H. -G. [2 ]
Garrido, F. [1 ,5 ]
Cabrera, T. [1 ,5 ]
机构
[1] Hosp Univ Virgen Nieves, Serv Anal Clin, Granada 18014, Spain
[2] Univ Tubingen, Inst Cell Biol, Dept Immunol, Tubingen, Germany
[3] Univ Tubingen Hosp, Urol Clin, Tubingen, Germany
[4] Hosp Univ Virgen Nieves, Serv Anat Patol, Granada 18014, Spain
[5] Univ Granada, Dept Bioquim & Biol Mol Inmunol 3, Granada, Spain
[6] Hosp Univ Virgen Nieves, Serv Urol, Granada 18014, Spain
来源
TISSUE ANTIGENS | 2010年 / 75卷 / 02期
关键词
human leukocyte antigen class I; immunohistochemistry; microdissection; normal renal tissue; renal cell carcinoma; CHROMOSOME REGION 6P21; HIGH-FREQUENCY; DOWN-REGULATION; MELANOMA-CELLS; COLORECTAL CARCINOMAS; LARYNGEAL CARCINOMAS; ALTERED PHENOTYPES; CERVICAL-CANCER; ANTIGEN; TUMORS;
D O I
10.1111/j.1399-0039.2009.01409.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
A total of 93 frozen primary renal cell carcinoma (RCC) samples and 31 frozen samples of corresponding normal renal tissue were analyzed for human leukocyte antigen (HLA) class I and HLA-DR expression. Unexpectedly, HLA class I expression was much higher on RCC cells than on normal renal tubular cells. Immunohistochemistry analysis of frozen and paraffin-embedded tissue samples, applying an extended panel of specific anti-HLA monoclonal antibodies, showed elevated HLA class I antigen expression in 95.6% of the tumors vs only 12.9% of normal renal tissues. These findings were confirmed by molecular analysis of HLA heavy chain and beta 2-microglobulin (beta 2m) transcription levels using quantitative real-time polymerase chain reaction (PCR) on microdissected tissue samples (isolated tumor nests and autologous normal renal tubules) from four patients. These results might help to explain the relatively high success rate of immunotherapy in patients with RCC. The molecular mechanism underlying the increased HLA class I expression in RCC has yet to be elucidated.
引用
收藏
页码:110 / 118
页数:9
相关论文
共 47 条
[11]   The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression [J].
Camuesco, D ;
Comalada, M ;
Rodriguez-Cabezas, ME ;
Nieto, A ;
Lorente, MD ;
Concha, A ;
Zarzuelo, A ;
Gálvez, J .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (07) :908-918
[12]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[13]  
COZAR JM, 2002, REV UROL, V3, P62
[14]   THE DETAILED DISTRIBUTION OF HLA-A-ANTIGEN, B-ANTIGEN, C-ANTIGEN IN NORMAL HUMAN ORGANS [J].
DAAR, AS ;
FUGGLE, SV ;
FABRE, JW ;
TING, A ;
MORRIS, PJ .
TRANSPLANTATION, 1984, 38 (03) :287-292
[15]   Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas [J].
Dengjel, Jorn ;
Nastke, Maria-Dorothea ;
Gouttefangeas, Cecile ;
Gitsioudis, Gitsios ;
Schoor, Oliver ;
Altenberend, Florian ;
Mueller, Margret ;
Kraemer, Bjoern ;
Missiou, Anna ;
Sauter, Martina ;
Hennenlotter, Joerg ;
Wernet, Dorothee ;
Stenzl, Arnulf ;
Rammensee, Hans-Georg ;
Klingel, Karin ;
Stevanovic, Stefan .
CLINICAL CANCER RESEARCH, 2006, 12 (14) :4163-4170
[16]   LACK OF HLA CLASS-I ANTIGEN EXPRESSION BY CULTURED MELANOMA-CELLS FO-1 DUE TO A DEFECT IN B2M GENE-EXPRESSION [J].
DURSO, CM ;
WANG, ZG ;
CAO, Y ;
TATAKE, R ;
ZEFF, RA ;
FERRONE, S .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (01) :284-292
[17]   Microsatellite analysis of microdissected tumor cells and 6p high density microsatellite analysis in head and neck squamous cell carcinomas with down-regulated human leukocyte antigen class I expression [J].
Feenstra, M ;
Verdaasdonk, M ;
van der Zwan, AW ;
de Weger, R ;
Slootweg, P ;
Tilanus, M .
LABORATORY INVESTIGATION, 2000, 80 (03) :405-414
[18]   LOSS OF HLA CLASS-I ANTIGENS BY MELANOMA-CELLS - MOLECULAR MECHANISMS, FUNCTIONAL-SIGNIFICANCE AND CLINICAL RELEVANCE [J].
FERRONE, S ;
MARINCOLA, FM .
IMMUNOLOGY TODAY, 1995, 16 (10) :487-494
[19]   Renal cell carcinoma: Management of advanced disease [J].
Figlin, RA .
JOURNAL OF UROLOGY, 1999, 161 (02) :381-386
[20]   MHC antigens and tumor escape from immune surveillance [J].
Garrido, F ;
Algarra, I .
ADVANCES IN CANCER RESEARCH, VOL 83, 2001, 83 :117-158